Atlas Trials

Afatinib in Advanced Refractory Urothelial Cancer

Clinical trial NCT02122172 · TERMINATED

Trial details

NCT number
NCT02122172
Sponsor
University of Chicago
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Distal Urethral CancerProximal Urethral CancerRecurrent Bladder CancerRecurrent Urethral CancerStage III Bladder CancerStage III Urethral CancerStage IV Bladder CancerStage IV Urethral CancerUreter Cancer
Start date
2017-09-13
Primary completion
2024-04-04
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.